by rss feed | Mar 8, 2026 | News Feeds, Prasad out, Texas AG, weekly reads
Before we dive into the weekly reads, I wanted to explain something new on The Niche and ask for your support of our brain tumor research. Brain tumor research funding As many of you know, some firsthand, funding is extremely difficult to get these days. This is...
by rss feed | Mar 1, 2026 | longevity hype, News Feeds, weekly reads
The stream of longevity hype can be exhausting, but there’s exciting research in this space too. This week there was some of both. It was also a wild week in the news for the FDA and its CBER branch too. Longevity hype vs. data from new research Can humans...
by rss feed | Feb 15, 2026 | Dwarfish therapy, News Feeds, Ozempic cartilage, weekly reads
It’s discouraging to see many media outlets posting sponsored content on stem cells and I never thought I’d see such an advertorial in The Atlantic. Yet there it was! Sponsored content on stem cells from The Atlantic Here it is: Stem Cell Transplantation’s...
by rss feed | Feb 8, 2026 | Casgevy challenge, News Feeds, weekly reads
It was exciting when the combined cell and gene therapies Casgevy and Lyfgenia were approved for sickle cell in late 2023. Still, one of the anticipated challenges was that the therapies could be so expensive that it would limit access. However, since the approval...
by rss feed | Feb 1, 2026 | News Feeds, Renewal Bio, SCBEM, weekly reads
Scientists sometimes disagree about research including not just what data might mean, but also what kinds of rules there should be about research like stem cell-based embryo models (SCBEM). It makes sense that the most cutting-edge research tends to spark the...
by rss feed | Jan 25, 2026 | ESC ban, News Feeds, stem cell IVF, weekly reads
NIH just announced a fetal tissue research ban. We can also expect an end (or close to it) to funding of human embryonic stem cell (hESC) research soon. There have been signs these were coming. Fetal tissue research ban, hESCs likely next Here’s the...
